ImmuCell Corporation
ICCC
$9.89
-$0.02-0.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.83M | 1.94M | -2.85M | -139.70K | 501.90K |
| Total Depreciation and Amortization | 470.60K | 528.30K | 706.30K | 679.10K | 668.20K |
| Total Amortization of Deferred Charges | 3.20K | 3.20K | 3.20K | 29.60K | 10.80K |
| Total Other Non-Cash Items | 259.90K | 153.70K | 2.84M | -92.60K | 20.80K |
| Change in Net Operating Assets | 450.70K | 946.20K | -215.00K | -1.66M | 399.80K |
| Cash from Operations | 3.02M | 3.57M | 482.50K | -1.18M | 1.60M |
| Capital Expenditure | -733.90K | -177.20K | -172.30K | -593.90K | -155.20K |
| Sale of Property, Plant, and Equipment | 0.00 | 10.00K | 5.00K | 1.90K | 29.20K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -733.90K | -167.20K | -167.30K | -592.00K | -125.90K |
| Total Debt Issued | -- | -- | 0.00 | 801.30K | -- |
| Total Debt Repaid | -402.50K | -400.00K | -394.60K | -1.12M | -381.40K |
| Issuance of Common Stock | 165.00K | 0.00 | 0.00 | 0.00 | 329.90K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -14.60K | -24.90K |
| Cash from Financing | -237.60K | -400.00K | -394.60K | -337.70K | -76.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.05M | 3.01M | -79.40K | -2.11M | 1.40M |